FDA Approves Welireg With Pembrolizumab for Renal Cell Carcinoma
Pembrolizumab-The U.S. Food and Drug Administration (FDA) has approved the combination of Welireg (belzutifan) and Pembrolizumab (Keytruda) for the treatment of certain patients with renal cell carcinoma (RCC), the most..
